| Quantum machine learning algorithms for drug discovery applications K Batra, KM Zorn, DH Foil, E Minerali, VO Gawriljuk, TR Lane, S Ekins Journal of chemical information and modeling 61 (6), 2641-2647, 2021 | 137 | 2021 |
| Comparing machine learning algorithms for predicting drug-induced liver injury (DILI) E Minerali, DH Foil, KM Zorn, TR Lane, S Ekins Molecular pharmaceutics 17 (7), 2628-2637, 2020 | 71 | 2020 |
| Bioactivity comparison across multiple machine learning algorithms using over 5000 datasets for drug discovery TR Lane, DH Foil, E Minerali, F Urbina, KM Zorn, S Ekins Molecular pharmaceutics 18 (1), 403-415, 2020 | 47 | 2020 |
| Machine learning for discovery of GSK3β inhibitors PA Vignaux, E Minerali, DH Foil, AC Puhl, S Ekins ACS omega 5 (41), 26551-26561, 2020 | 35 | 2020 |
| The antiviral drug tilorone is a potent and selective inhibitor of acetylcholinesterase PA Vignaux, E Minerali, TR Lane, DH Foil, PB Madrid, AC Puhl, S Ekins Chemical research in toxicology 34 (5), 1296-1307, 2021 | 24 | 2021 |
| Evaluation of assay central machine learning models for rat acute oral toxicity prediction E Minerali, DH Foil, KM Zorn, S Ekins ACS Sustainable Chemistry & Engineering 8 (42), 16020-16027, 2020 | 20 | 2020 |
| Asymmetric synthesis of novel spirocycles via a chiral phosphoric acid catalyzed desymmetrization AM Kelley, E Minerali, JE Wilent, NJ Chambers, KJ Stingley, GT Wilson, ... Tetrahedron Letters 60 (18), 1262-1264, 2019 | 18 | 2019 |
| A very large-Scale bioactivity comparison of deep learning and multiple machine learning algorithms for drug discovery TR Lane, DH Foil, E Minerali, F Urbina, KM Zorn | 2 | 2020 |
| Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer AC Puhl, R Raman, TM Havener, E Minerali, AJ Hickey, S Ekins ACS omega 9 (10), 11870-11882, 2024 | | 2024 |
| Optimizing Tilorone Analogs as Acetylcholinesterase Inhibitors Using Machine Learning and Recurrent Neural Networks A Puhl, A Vignaux, E Minerali, TR Lane, DH Foil, KM Zorn, F Urbina, ... NEUROTHERAPEUTICS 18 (3), 2150-2150, 2021 | | 2021 |
| Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach AC Puhl, PA Vignaux, E Minerali, JJ Klein, TM Havener, E Anderson, ... Molecular Genetics and Metabolism 132 (2), S88-S89, 2021 | | 2021 |
| A Drug Discovery Platform to Identify Chaperones for Lysosomal Storage Diseases AC Puhl, JJ Klein, PA Vignaux, E Minerali, D Foil, KM Zorn, S Ekins NEUROTHERAPEUTICS 17 (3), 1313-1313, 2020 | | 2020 |
| Asymmetric Synthesis of Enantioenriched Spirocycles via a Chiral Brønsted Acid Catalyzed Desymmetrization E Minerali The University of North Carolina at Greensboro, 2019 | | 2019 |